History | Eculizumab for treating refractory myasthenia gravis (terminated appraisal) | Guidance | NICE

History

Invitation to participate

Final scope (PDF 206 KB)

Published:

07 July 2017
Final matrix (PDF 263 KB)

Published:

07 July 2017
NICE's response to comments on the draft scope and provisional matrix (PDF 451 KB)

Published:

07 July 2017
Equality impact assessment (Scoping) (PDF 175 KB)

Published:

07 July 2017

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 251 KB)

Published:

22 June 2017
Draft matrix pre referral (PDF 255 KB)

Published:

22 June 2017